Search Results

AgaMatrix JAZZ™ Blood Glucose Monitoring System is intended for the quantitative measurement of glucose in fresh capillary whole blood from the finger stick, palm, and/or forearm. Testing is done outside the body (in vitro diagnostic use). It is indicated for use at home (over the counter (OTC) ) by persons with diabetes, or in a clinical setting by healthcare professionals, as an aid to monitor the effectiveness of diabetes control.

AgaMatrix JAZZ™ Blood Glucose Meter is intended for use with AgaMatrix JAZZ™ Blood Glucose Test Strips for the quantitative measurement of glucose in fresh capillary whole blood from the finger stick, palm, and/or forearm. Testing is done outside the body (in vitro diagnostic use). It is indicated for use at home (over the counter (OTC) ) by persons with diabetes, or in a clinical setting by healthcare professionals, as an aid to monitor the effectiveness of diabetes control.

AgaMatrix JAZZ™ Blood Glucose Test Strips are intended for use with AgaMatrix JAZZ™ Blood Glucose Meter for the quantitative measurement of glucose in fresh capillary whole blood from the finger stick, palm and/or forearm. Testing is done outside the body (in vitro diagnostic use). It is indicated for use at home (over the counter (OTC) ) by persons with diabetes, or in a clinical setting by healthcare professionals, as an aid to monitor the effectiveness of diabetes control.

AgaMatrix JAZZ™ Control Solutions are intended for use with the AgaMatrix JAZZ™ Meter and AgaMatrix JAZZ™ Test Strips as a quality control check to verify the accuracy of blood glucose test results.

The AgaMatrix WaveSense JAZZ™ Blood Glucose Monitoring System includes a meter with batteries, compact carrying case, Lancing device, lancets, control solution and owner's booklet. Test Strips are sold separately. It is intended for over-the-counter home use by diabetics to monitor their blood glucose levels, or for use in a clinical setting by healthcare professionals. The system tests fresh capillary whole blood. The meter is a portable, battery-operated instrument.

The provided text is a 510(k) Summary for the AgaMatrix WaveSense JAZZ™ Blood Glucose Monitoring System, dated August 17, 2007. It states the device's intended use and that it complies with ISO 15197:2003, but it does not contain information about specific acceptance criteria or a study proving the device directly meets acceptance criteria for accuracy with detailed performance metrics.

The document discusses the device's modification (no coding required), intended use, and compliance with various international standards, including ISO 15197:2003 ("In vitro diagnostic test systems- Requirements for blood glucose monitoring systems for self-testing in managing diabetes mellitus"). While compliance with ISO 15197 generally implies meeting certain accuracy standards, the specific performance data (e.g., mean absolute relative difference (MARD), percentages within certain error grids) are not present in this summary.

Therefore, I cannot fulfill all parts of your request based solely on the provided text.

Here's what I can provide based on the given information, along with explanations for the missing elements:

1. A table of acceptance criteria and the reported device performance

• Acceptance Criteria: The document states compliance with ISO 15197:2003. This standard sets performance requirements for blood glucose monitoring systems.
  • ISO 15197:2003 Acceptance Criteria (generally, not explicitly stated in the document, but implied by compliance):
    • For glucose concentrations < 75 mg/dL (4.2 mmol/L), ≥ 95% of results shall fall within ±15 mg/dL (±0.83 mmol/L) of the reference method.
    • For glucose concentrations ≥ 75 mg/dL (4.2 mmol/L), ≥ 95% of results shall fall within ±20% of the reference method.
• Reported Device Performance: The provided text does not include specific performance data (e.g., study results, MARD, percentages meeting ISO criteria). It only states, "The system performs as intended and raises no new safety of effectiveness issues." This is a general conclusion, not a data-driven performance report.

2. Sample size used for the test set and the data provenance (e.g. country of origin of the data, retrospective or prospective)

• Sample Size for Test Set: Not specified in the provided text.
• Data Provenance (country of origin, retrospective/prospective): Not specified in the provided text.

3. Number of experts used to establish the ground truth for the test set and the qualifications of those experts (e.g. radiologist with 10 years of experience)

• Ground Truth Establishment for Test Set: This information is not provided. For blood glucose monitoring systems, ground truth is typically established using a highly accurate laboratory reference method (e.g., YSI analyzer), rather than expert consensus.

4. Adjudication method (e.g. 2+1, 3+1, none) for the test set

• Adjudication Method: Not applicable or not specified. For blood glucose meters, the "ground truth" is determined by a lab reference method, not by expert adjudication of interpretations.

5. If a multi-reader multi-case (MRMC) comparative effectiveness study was done, If so, what was the effect size of how much human readers improve with AI vs without AI assistance

• MRMC Study: Not applicable. This device is a blood glucose meter, not an AI-assisted diagnostic imaging device that involves human "readers."

6. If a standalone (i.e., algorithm only without human-in-the-loop performance) was done

• Standalone Performance: For a blood glucose meter, the "standalone" performance refers to the device's accuracy when measuring blood glucose. While the document implies this was evaluated to meet ISO 15197, the specific results of such a study are not reported in this summary.

7. The type of ground truth used (expert consensus, pathology, outcomes data, etc.)

• Type of Ground Truth: Implied to be a laboratory reference method for blood glucose measurement (e.g., YSI glucose analyzer), as is standard for blood glucose meter validation. However, this is not explicitly stated in the provided text.

8. The sample size for the training set

• Sample Size for Training Set: Not applicable or not specified. Traditional blood glucose meters are not typically "trained" in the same way machine learning algorithms are. Their performance is based on the underlying electrochemistry and hardware design, and then validated through testing.

9. How the ground truth for the training set was established

• Ground Truth for Training Set: Not applicable. (See #8).

Ask a specific question about this device